ARMP
Price
$2.40
Change
-$0.02 (-0.83%)
Updated
Jul 18 closing price
Capitalization
86.86M
24 days until earnings call
BOLT
Price
$5.53
Change
-$0.21 (-3.66%)
Updated
Jul 18 closing price
Capitalization
10.6M
17 days until earnings call
Interact to see
Advertisement

ARMP vs BOLT

Header iconARMP vs BOLT Comparison
Open Charts ARMP vs BOLTBanner chart's image
Armata Pharmaceuticals
Price$2.40
Change-$0.02 (-0.83%)
Volume$6.84K
Capitalization86.86M
Bolt Biotherapeutics
Price$5.53
Change-$0.21 (-3.66%)
Volume$21.71K
Capitalization10.6M
ARMP vs BOLT Comparison Chart in %
Loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. BOLT commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a Hold and BOLT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ARMP: $2.40 vs. BOLT: $5.53)
Brand notoriety: ARMP and BOLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 2% vs. BOLT: 66%
Market capitalization -- ARMP: $86.86M vs. BOLT: $10.6M
ARMP [@Biotechnology] is valued at $86.86M. BOLT’s [@Biotechnology] market capitalization is $10.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileBOLT’s FA Score has 1 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • BOLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARMP and BOLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 4 TA indicator(s) are bullish while BOLT’s TA Score has 2 bullish TA indicator(s).

  • ARMP’s TA Score: 4 bullish, 3 bearish.
  • BOLT’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ARMP is a better buy in the short-term than BOLT.

Price Growth

ARMP (@Biotechnology) experienced а +8.11% price change this week, while BOLT (@Biotechnology) price change was -10.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ARMP is expected to report earnings on Aug 13, 2025.

BOLT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARMP($86.9M) has a higher market cap than BOLT($10.6M). ARMP YTD gains are higher at: 29.730 vs. BOLT (-48.327). ARMP has higher annual earnings (EBITDA): 13.5M vs. BOLT (-61.54M). BOLT has more cash in the bank: 38.8M vs. ARMP (11.7M). BOLT has less debt than ARMP: BOLT (24.7M) vs ARMP (135M). BOLT has higher revenues than ARMP: BOLT (3.64M) vs ARMP (0).
ARMPBOLTARMP / BOLT
Capitalization86.9M10.6M820%
EBITDA13.5M-61.54M-22%
Gain YTD29.730-48.327-62%
P/E RatioN/AN/A-
Revenue03.64M-
Total Cash11.7M38.8M30%
Total Debt135M24.7M547%
FUNDAMENTALS RATINGS
ARMP: Fundamental Ratings
ARMP
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARMPBOLT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCG5.900.70
+13.46%
Oriental Culture Holding Ltd
FSLR175.852.31
+1.33%
First Solar
TCBI89.730.26
+0.29%
Texas Capital Bancshares
CMP20.54-0.15
-0.72%
Compass Minerals International
ARBB5.50-0.08
-1.43%
ARB IOT Group Limited

ARMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARMP has been loosely correlated with PTIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARMP jumps, then PTIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-0.83%
PTIX - ARMP
45%
Loosely correlated
-3.12%
CTNM - ARMP
32%
Poorly correlated
+13.28%
BOLT - ARMP
31%
Poorly correlated
-3.66%
TNGX - ARMP
31%
Poorly correlated
-1.31%
FGHQF - ARMP
25%
Poorly correlated
N/A
More

BOLT and

Correlation & Price change

A.I.dvisor tells us that BOLT and ELVN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and ELVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
-3.66%
ELVN - BOLT
32%
Poorly correlated
-2.91%
LEGN - BOLT
31%
Poorly correlated
-1.28%
XENE - BOLT
30%
Poorly correlated
N/A
ARMP - BOLT
29%
Poorly correlated
-0.83%
BHVN - BOLT
29%
Poorly correlated
-7.02%
More